FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer
FDA批准摘要:奥拉帕尼单药治疗或与贝伐珠单抗联合治疗晚期卵巢癌患者的维持治疗
期刊:Oncologist
影响因子:4.2
doi:10.1002/onco.13551
Arora, Shaily; Balasubramaniam, Sanjeeve; Zhang, Hui; Berman, Tara; Narayan, Preeti; Suzman, Daniel; Bloomquist, Erik; Tang, Shenghui; Gong, Yutao; Sridhara, Rajeshwari; Turcu, Francisca Reyes; Chatterjee, Deb; Saritas-Yildirim, Banu; Ghosh, Soma; Philip, Reena; Pathak, Anand; Gao, Jennifer J; Amiri-Kordestani, Laleh; Pazdur, Richard; Beaver, Julia A